Atea Pharmaceuticals (AVIR) Stock Chart & Stock Price History → A new way to collect income from stocks (From DTI) (Ad) Free AVIR Stock Alerts $3.70 -0.10 (-2.63%) (As of 06/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Atea Pharmaceuticals Stock Price Performance5 Day Performance-1.86%1 Month Performance-5.85%3 Month Performance-7.50%6 Month Performance+22.92%Year-To-Date Performance+21.31%1 Year Performance-9.98% Receive AVIR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad WealthPressOptions expert shares his top option strategy for freeA 35 year old man from central Florida has stumbled on one of the best strategies we’ve seen in a long time. For the last 30 months his “Friday to Monday” trading strategy has maintained a 71% win rate on more than 350 trades. That includes multiple big time winners like 82% from Adobe… 77% from Palo Alto… But also a barrage of smaller winners like 20% from AMC… Each of which were opened on a Friday afternoon and closed the very next Monday morning. As you’ll see in his brand new video, this strange strategy has given him the ability to capture big time market moves over the weekend.Check it out, simply follow this link here. AVIR Stock Chart for Sunday, June, 9, 2024 AVIR Chart by TradingView Atea Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$3.80$3.70-2.63%$3.85$3.70162,231 shs$311.61 million06/06/2024$3.96$3.80-4.04%$3.95$3.80221,140 shs$320.04 million06/05/2024$3.77$3.96+5.04%$4.01$3.80302,630 shs$333.51 million06/04/2024$3.89$3.77-3.08%$3.87$3.75129,358 shs$317.51 million06/03/2024$3.67$3.89+5.99%$3.89$3.64266,433 shs$327.62 million05/31/2024$3.61$3.67+1.66%$3.71$3.62141,116 shs$309.09 million Get the Latest News and Ratings for AVIR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$3.53$3.61+2.27%$3.67$3.56167,322 shs$304.05 million05/29/2024$3.61$3.53-2.22%$3.71$3.52330,501 shs$297.30 million05/28/2024$3.66$3.61-1.37%$3.70$3.58249,813 shs$304.03 million05/27/2024$3.66$3.66$3.73$3.64148,400 shs$308.25 million05/24/2024$3.69$3.66-0.81%$3.73$3.65148,474 shs$308.25 million05/23/2024$3.82$3.69-3.40%$3.81$3.68163,822 shs$310.77 million05/22/2024$3.61$3.82+5.82%$3.86$3.60493,535 shs$321.72 million05/21/2024$3.60$3.61+0.28%$3.70$3.59167,612 shs$304.03 million05/20/2024$3.65$3.60-1.37%$3.72$3.57318,862 shs$303.20 million05/17/2024$3.70$3.65-1.35%$3.76$3.65320,357 shs$307.40 million05/16/2024$3.71$3.70-0.27%$3.74$3.66523,247 shs$311.63 million05/15/2024$3.96$3.71-6.31%$3.92$3.65725,614 shs$312.46 million05/14/2024$4.04$3.96-1.98%$4.14$3.93262,627 shs$333.51 million05/13/2024$3.89$4.04+3.86%$4.07$3.88200,810 shs$340.25 million05/10/2024$3.93$3.89-1.02%$3.99$3.88155,488 shs$327.62 million05/09/2024$3.93$3.93$4.02$3.89207,864 shs$330.99 million05/08/2024$3.94$3.93-0.25%$3.94$3.85127,937 shs$330.99 million05/07/2024$4.00$3.94-1.50%$4.00$3.91143,692 shs$331.83 million05/06/2024$3.96$4.00+1.01%$4.00$3.89288,222 shs$336.88 million05/03/2024$3.83$3.96+3.39%$3.96$3.80164,689 shs$333.51 million05/02/2024$3.85$3.83-0.52%$3.86$3.79165,720 shs$322.56 million05/01/2024$3.70$3.85+4.05%$3.94$3.73405,229 shs$324.25 million04/30/2024$3.71$3.70-0.27%$3.77$3.69227,778 shs$311.43 million04/29/2024$3.71$3.71$3.77$3.70175,467 shs$312.27 million04/26/2024$3.69$3.71+0.54%$3.72$3.65143,066 shs$312.27 million04/25/2024$3.70$3.69-0.27%$3.75$3.67174,617 shs$310.59 million04/24/2024$3.73$3.70-0.80%$3.74$3.68196,517 shs$311.43 million04/23/2024$3.67$3.73+1.63%$3.82$3.68180,547 shs$313.95 million04/22/2024$3.72$3.67-1.34%$3.76$3.66345,154 shs$308.90 million04/19/2024$3.70$3.72+0.54%$3.77$3.67217,747 shs$313.11 million04/18/2024$3.71$3.70-0.27%$3.76$3.68267,758 shs$311.43 million04/17/2024$3.74$3.71-0.80%$3.79$3.71251,669 shs$312.25 million04/16/2024$3.76$3.74-0.53%$3.78$3.72129,108 shs$314.80 million04/15/2024$3.76$3.76$3.86$3.72219,423 shs$316.48 millionA new way to collect income from stocks (Ad)Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera.04/12/2024$3.85$3.76-2.34%$3.89$3.73171,065 shs$316.48 million04/11/2024$3.77$3.85+2.12%$3.89$3.79158,848 shs$324.05 million04/10/2024$3.81$3.77-1.05%$3.78$3.73266,478 shs$317.32 million04/09/2024$3.76$3.81+1.33%$3.85$3.77116,700 shs$320.69 million04/08/2024$3.81$3.76-1.31%$3.83$3.74216,739 shs$316.48 million04/05/2024$3.85$3.81-1.04%$3.90$3.81137,984 shs$320.69 million04/04/2024$3.90$3.85-1.28%$4.01$3.83275,369 shs$324.05 million04/03/2024$3.87$3.90+0.78%$3.93$3.83165,970 shs$328.26 million04/02/2024$4.00$3.87-3.25%$4.00$3.87205,599 shs$325.74 million04/01/2024$4.04$4.00-0.99%$4.03$3.91321,449 shs$336.68 million03/29/2024$4.04$4.04$4.09$3.98374,018 shs$340.05 million03/28/2024$4.00$4.04+1.00%$4.09$3.98374,017 shs$340.05 million03/27/2024$3.77$4.00+6.10%$4.05$3.87366,043 shs$336.68 million03/26/2024$3.82$3.77-1.31%$3.89$3.77242,551 shs$317.32 million03/25/2024$4.06$3.82-5.91%$4.05$3.79592,661 shs$321.53 million03/22/2024$4.10$4.06-0.98%$4.14$3.98254,730 shs$341.73 million03/21/2024$3.95$4.10+3.80%$4.12$3.901.05 million shs$345.10 million03/20/2024$3.94$3.95+0.25%$3.99$3.71490,321 shs$332.47 million03/19/2024$4.00$3.94-1.50%$4.03$3.911.07 million shs$331.63 million03/18/2024$4.01$4.00-0.25%$4.03$3.88268,663 shs$336.68 million03/15/2024$3.85$4.01+4.16%$4.02$3.80614,416 shs$337.52 million03/14/2024$3.99$3.85-3.51%$3.96$3.81241,787 shs$324.04 million03/13/2024$4.00$3.99-0.25%$4.06$3.98142,932 shs$335.82 million03/12/2024$4.03$4.00-0.74%$4.06$3.96208,375 shs$336.68 million03/11/2024$4.00$4.03+0.75%$4.18$4.00268,639 shs$339.21 million03/08/2024$4.08$4.00-1.96%$4.12$3.96186,282 shs$336.68 million Related Companies: Inovio Pharmaceuticals Stock Price Chart MannKind Stock Price Chart Mirum Pharmaceuticals Stock Price Chart Prothena Stock Price Chart Calliditas Therapeutics AB (publ) Stock Price Chart Day One Biopharmaceuticals Stock Price Chart Arcturus Therapeutics Stock Price Chart AbCellera Biologics Stock Price Chart Liquidia Stock Price Chart Collegium Pharmaceutical Stock Price Chart Receive AVIR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVIR) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companie...Banyan Hill Publishing | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atea Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atea Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.